Recruiting at 1 site No phase Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Disease study: Experimental group

Official title Electrical Stimulation for Respiratory and Leg Muscles Impact on COPD Patients

ClinicalTrials.gov ID: NCT06670443

What this study is testing

What it's testing
This study is testing whether adding electrical patches to regular breathing and leg exercises improves breathing and walking in COPD patients.
Who it's for
You may be able to join if you have COPD and can do regular breathing and leg exercises.
What's involved
You will wear small patches on your chest and legs while you do breathing and leg exercises at home. The patches send gentle electric signals to help the muscles work better.
Time commitment
The study lasts several weeks and you will need to wear the patches and do the exercises at home each day, with a few check‑in visits with the study team.
  • You might receive a placebo (an inactive treatment) instead of the study drug.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 40 to 65

You may be able to join if

  • Patient undergoes four main clinical criteria for the diagnosis of RLS according to the international restless leg syndrome study group (IRLSSG)...
  • an urge to move legs that is usually associated with paresthesia.
  • alleviation of the symptoms by moving the legs.
  • aggravation or exacerbation of the symptoms particularly at rest or during sitting or lying down in the bed.
  • worsening of the signs at night. patients with diagnosed with grade I and grade II COPD their ages ranged between 45-55 o All patients will be...

You likely can't join if

  • History of Deep venous thrombosis
  • History of Bleeding disorders
  • Have an implantable device like a pacemaker
  • Recent Infected wound
  • History of allergic response to the electrodes, gel or tape
  • patients who participating in any other exercise program
See the full eligibility criteria
Who can join
  • Patient undergoes four main clinical criteria for the diagnosis of RLS according to the international restless leg syndrome study group (IRLSSG) including
  • an urge to move legs that is usually associated with paresthesia.
  • alleviation of the symptoms by moving the legs.
  • aggravation or exacerbation of the symptoms particularly at rest or during sitting or lying down in the bed.
  • worsening of the signs at night. patients with diagnosed with grade I and grade II COPD their ages ranged between 45-55 o All patients will be clinically and medically stable when attending the study
What rules you out
  • History of Deep venous thrombosis
  • History of Bleeding disorders
  • Have an implantable device like a pacemaker
  • Recent Infected wound
  • History of allergic response to the electrodes, gel or tape
  • patients who participating in any other exercise program
  • Loss of sensation or numbness

The study team makes the final eligibility decision.

Where it is enrolling

  • Dokki, Egypt

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 40 years to 65 years. The study team makes the final eligibility decision.

Where is this trial taking place?

This study is enrolling now at Dokki, Egypt. Enter your location above to see the nearest enrolling site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.